Showing results (251-260 of 531) with videos related to
Sort By:
Pageof 54
Heart (British Cardiac Society)|September 17, 2003
Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trialsH S Gurm, D L Bhatt, A M Lincoff, et al.JACC. Heart Failure|October 16, 2025
Prevalence and Associations of Systemic Inflammation in Heart Failure Across the Spectrum of Ejection FractionBarry A Borlaug, Cecilie Holse, Mette Holme Jung, et al.Journal of the American Heart Association|August 2, 2021
Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial InfarctionRaunak Nair, Michael Johnson, Kathleen Kravitz, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 20, 2013
Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trialsTobias Geisler, Karin Müller, Athanasios Karathanos, et al.The American Journal of Cardiology|April 27, 2000
The benefit of abciximab in percutaneous coronary revascularization is not device-specificD L Bhatt, A M Lincoff, R M Califf, et al.American Heart Journal|October 28, 1999
Effect of institutional volume and academic status on outcomes of coronary interventions: the IMPACT-II experienceI C Gilchrist, L H Gardner, J B Muhlestein, et al.Archives of Internal Medicine|November 26, 2003
In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysisHerbert D Aronow, Gian M Novaro, Michael S Lauer, et al.JAMA Cardiology|March 7, 2019
Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 TrialPreethi Mani, Rishi Puri, Gregory G Schwartz, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 20, 2025
Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes TrialStephen J Nicholls, Kausik K Ray, A Michael Lincoff, et al.Clinical Cardiology|April 2, 2026
Sex Differences in Statin Intolerance: Insights From the CLEAR Outcomes TrialSahar Naderi, Danielle Brennan, Na Li, et al.Pageof 54